Science Explorer Back to mapMap
Discussion
Company · Tampa · United States

Romark (United States)

romark.comROR OpenAlex
Research works
30
▼ 50% vs 2018-21
Citations
2.1k
70.0 per fractional work
Top-10% rate
14.2%
all institutions 10.0%
Open access
52%
world 40%
International
52%
world 18%
Romark (United States)

Not ranked overall: Romark (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Romark (United States) work in?

In all years, 57% of research at Romark (United States) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (54%), Immunology and Microbiology (14%), Chemistry (11%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 17 fractional works · 57.2% of its workMedicine: 16 fractional works · 54.4% of its workInfectious Diseases: 6 fractional works · 18.3% of its workEpidemiology: 5 fractional works · 16.6% of its workHepatology: 3 fractional works · 9.1% of its workGastroenterology: 1 fractional works · 2.3% of its workPathology and Forensic Medicine: 1 fractional works · 2.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.9% of its workPhysiology: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 0.8% of its workRheumatology: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workOncology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.1% of its workEmergency Medical Services: 0 fractional works · 1.1% of its workNursing: 0 fractional works · 1.1% of its workNutrition and Dietetics: 0 fractional works · 1.1% of its workVeterinary: 0 fractional works · 0.6% of its workSmall Animals: 0 fractional works · 0.6% of its workLife Sciences: 9 fractional works · 29.9% of its workImmunology and Microbiology: 4 fractional works · 14.3% of its workParasitology: 3 fractional works · 10.3% of its workImmunology: 1 fractional works · 2.4% of its workVirology: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 8.2% of its workMolecular Biology: 2 fractional works · 7.8% of its workSmaller subfields together: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 2 fractional works · 5.0% of its workAnimal Science and Zoology: 1 fractional works · 2.5% of its workPlant Science: 0 fractional works · 1.7% of its workAgronomy and Crop Science: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.2% of its workPharmacology: 1 fractional works · 2.2% of its workNeuroscience: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 12.3% of its workChemistry: 3 fractional works · 10.7% of its workOrganic Chemistry: 3 fractional works · 10.7% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workEnvironmental Science: 0 fractional works · 0.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.6% of its workALL ITS WORKRomark (UnitedStates)30fractional works, all years
Life Sciences30%Physical Sciences12%Health Sciences57%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1654.4%
    2. Health Professions01.1%
    3. Nursing01.1%
    4. Veterinary00.6%
    1. Immunology and Microbiology414.3%
    2. Biochemistry, Genetics and Molecular Biology28.2%
    3. Agricultural and Biological Sciences25.0%
    4. Pharmacology, Toxicology and Pharmaceutics12.2%
    5. Neuroscience00.3%
    1. Chemistry310.7%
    2. Computer Science00.8%
    3. Environmental Science00.8%
    1. Social Sciences00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Romark (United States)?

Ranked on the quality score, Jean François Rossignol, Jean‐François Rossignol and Matthew C. Bardin lead among researchers whose main affiliation is Romark (United States).

  1. 1 Jean François Rossignol United States · #563,528 worldwide 1.8k citations · 29 works
  2. 2 Jean‐François Rossignol United States · #567,825 worldwide 5.2k citations · 109 works
  3. 3 Matthew C. Bardin United States · #2,320,566 worldwide 400 citations · 17 works
All ranked researchers at Romark (United States)

What are the most cited papers from Romark (United States)?

The most cited paper from Romark (United States) is "Nitazoxanide: A first-in-class broad-spectrum antiviral agent" (Jean‐François Rossignol, 2014), with 578 citations. Next come "Treatment of Diarrhea Caused by Cryptosporidium parvum: A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of Nitazoxanide" (359) and "Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus" (301).

Most cited papers
#PaperReleasedCitations
1 Nitazoxanide: A first-in-class broad-spectrum antiviral agent Jean‐François Rossignol · Antiviral Research Open access 6 Aug 2014 578
2 Treatment of Diarrhea Caused by Cryptosporidium parvum: A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of Nitazoxanide Jean-François Rossignol, Ayman Ayoub, Marc S. Ayers · The Journal of Infectious Diseases Jul 2001 359
3 Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus Jean‐François Rossignol · Journal of Infection and Public Health Open access 18 Apr 2016 301
4 Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial Jason Haffizulla, Aaron L. Hartman, Melanie Hoppers et al. · The Lancet Infectious Diseases Open access 19 May 2014 264
5 Nitazoxanide for the Treatment of Clostridium difficile Colitis Daniel M. Musher, Nancy D. Logan, Richard J. Hamill et al. · Clinical Infectious Diseases 13 Jul 2006 250
All 91 most cited papers, with filters and sorting

Which keywords describe research at Romark (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Immune Response, Pathogenesis, Treatment, Vaccine, Antiviral Therapy, Liver Disease and Zoonotic Transmission.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology14▲ 11×16 topics
  2. Immune Response7▲ 38×9 topics
  3. Pathogenesis6▲ 33×5 topics
  4. Treatment4▲ 11×3 topics
  5. Vaccine4▲ 31×5 topics
  6. Antiviral Therapy4▲ 81×3 topics
  7. Liver Disease4▲ 88×2 topics
  8. Public Health3▲ 8.0×4 topics
  9. Zoonotic Transmission3▲ 107×4 topics
  10. Pandemic3▲ 21×3 topics
  11. Genetic Variation3▲ 28×2 topics
  12. Cryptosporidium2▲ 293×1 topic
  13. Giardia2▲ 293×1 topic
  14. Diagnosis2▲ 7.8×3 topics
  15. Hepatitis C Virus2▲ 144×1 topic
  16. Hepatocellular Carcinoma2▲ 35×2 topics
  17. Ribavirin2▲ 144×1 topic
  18. Antibodies2▲ 81×2 topics
  19. Synthesis2▲ 11×6 topics
  20. H1N12▲ 160×1 topic
  21. Influenza2▲ 127×2 topics
  22. Virus2▲ 48×1 topic
  23. Antimicrobial2▲ 22×4 topics
  24. Infection2▲ 20×2 topics
  25. Norovirus2▲ 93×1 topic
  26. Rotavirus2▲ 93×1 topic
  27. Global Burden2▲ 9.2×2 topics
  28. Medicinal Chemistry2▲ 13×4 topics
  29. Chronic Hepatitis B1▲ 87×1 topic
  30. Coronavirus1▲ 40×2 topics
  31. Entamoeba histolytica1▲ 238×1 topic
  32. Hepatitis B Virus1▲ 87×1 topic
  33. pyogenic liver abscess1▲ 238×1 topic
  34. Heterocycles1▲ 21×3 topics
  35. Vaccine Development1▲ 13×5 topics
  36. ACE2 Receptor1▲ 31×2 topics
  37. Anticancer Agents1▲ 14×2 topics
  38. Antiretroviral Therapy1▲ 15×4 topics
  39. Disease Burden1▲ 47×2 topics
  40. Heterocyclic Compounds1▲ 23×2 topics

Which research topics does Romark (United States) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, interferon and immune responses and Lipid Membrane Structure and Behavior.

SARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksinterferon and immune responses: 0 fractional worksLipid Membrane Structure and Behavior: 0 fractional worksSynthesis and biological activity: 0 fractional worksQuinazolinone synthesis and applications: 0 fractional worksClick Chemistry and Appl…0Click Chemistry and Applications: 0 fractional worksPharmacological Receptor Mechanisms and Effects: 0 fractional worksLong-Term Effects of COVID-19: 0 fractional worksViral Infections and Imm…0Viral Infections and Immunology Research: 0 fractional works
Infectious DiseasesImmunologyMolecular BiologyOrganic Chemistry2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  3. 3 interferon and immune responses Immunology 0 works
  4. 4 Lipid Membrane Structure and Behavior Molecular Biology 0 works
  5. 5 Synthesis and biological activity Organic Chemistry 0 works
  6. 6 Quinazolinone synthesis and applications Organic Chemistry 0 works
  7. 7 Click Chemistry and Applications Organic Chemistry 0 works
  8. 8 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
  9. 9 Long-Term Effects of COVID-19 Neurology 0 works
  10. 10 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.3%not open47.7%

World: 40% of research is openly available.

with international co-authors51.9%domestic only48.1%

World: 18% is written across borders.

How has Romark (United States)'s research output changed?

Output in 2022-2025 was 50% lower than in 2018-2021.

20002005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Romark (United States) as a percentage of every work published that year, 0.0000098% in 2023.

0.00010%0.00020%Romark (United States)0.0000078% in 2024200020102020

Fractional works of Romark (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tampa

All research institutions in Tampa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Romark (United States). Posts are plain text and can be reported.